156 related articles for article (PubMed ID: 15608144)
1. Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells.
Mollereau C; Mazarguil H; Zajac JM; Roumy M
Mol Pharmacol; 2005 Mar; 67(3):965-75. PubMed ID: 15608144
[TBL] [Abstract][Full Text] [Related]
2. Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model.
Kersanté F; Mollereau C; Zajac JM; Roumy M
Peptides; 2006 May; 27(5):980-9. PubMed ID: 16488058
[TBL] [Abstract][Full Text] [Related]
3. Staurosporine differentiation of NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells induces selectivity of NPFF activity towards opioid receptors.
Mollereau C; Zajac JM; Roumy M
Peptides; 2007 May; 28(5):1125-8. PubMed ID: 17418451
[TBL] [Abstract][Full Text] [Related]
4. Modulation by neuropeptide FF of the interaction of mu-opioid (MOP) receptor with G-proteins.
Kersanté F; Moulédous L; Zajac JM; Mollereau C
Neurochem Int; 2010; 56(6-7):768-73. PubMed ID: 20211672
[TBL] [Abstract][Full Text] [Related]
5. GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.
Moulédous L; Froment C; Dauvillier S; Burlet-Schiltz O; Zajac JM; Mollereau C
J Biol Chem; 2012 Apr; 287(16):12736-49. PubMed ID: 22375000
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells.
Moulédous L; Merker S; Neasta J; Roux B; Zajac JM; Mollereau C
Biochem Biophys Res Commun; 2008 Aug; 373(1):80-4. PubMed ID: 18544342
[TBL] [Abstract][Full Text] [Related]
7. Anti-analgesia of a selective NPFF2 agonist depends on opioid activity.
Roussin A; Serre F; Gouardères C; Mazarguil H; Roumy M; Mollereau C; Zajac JM
Biochem Biophys Res Commun; 2005 Oct; 336(1):197-203. PubMed ID: 16129413
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.
Quelven I; Roussin A; Zajac JM
Eur J Pharmacol; 2005 Jan; 508(1-3):107-14. PubMed ID: 15680260
[TBL] [Abstract][Full Text] [Related]
9. Regulation of endogenous human NPFF2 receptor by neuropeptide FF in SK-N-MC neuroblastoma cell line.
Ankö ML; Panula P
J Neurochem; 2006 Jan; 96(2):573-84. PubMed ID: 16336216
[TBL] [Abstract][Full Text] [Related]
10. Dual localization of neuropeptide FF receptors in the rat dorsal horn.
Gouardères C; Roumy M; Advokat C; Jhamandas K; Zajac JM
Synapse; 2000 Jan; 35(1):45-52. PubMed ID: 10579807
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of mu- and delta-opioid antinociception by neuropeptide FF receptors in young mice.
Desprat C; Zajac JM
Neuropeptides; 1997 Feb; 31(1):1-7. PubMed ID: 9574828
[TBL] [Abstract][Full Text] [Related]
12. Functional modulation of human delta opioid receptor by neuropeptide FF.
Ankö ML; Panula P
BMC Neurosci; 2005 Apr; 6():21. PubMed ID: 15804369
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide FF selectively attenuates the effects of nociceptin on acutely dissociated neurons of the rat dorsal raphe nucleus.
Roumy M; Zajac J
Brain Res; 1999 Oct; 845(2):208-14. PubMed ID: 10536200
[TBL] [Abstract][Full Text] [Related]
14. Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF(1) and NPFF(2)) receptors.
Talmont F; Garcia LP; Mazarguil H; Zajac JM; Mollereau C
Neurochem Int; 2009 Dec; 55(8):815-9. PubMed ID: 19682524
[TBL] [Abstract][Full Text] [Related]
15. Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity.
Roumy M; Lorenzo C; Mazères S; Bouchet S; Zajac JM; Mollereau C
J Biol Chem; 2007 Mar; 282(11):8332-42. PubMed ID: 17224450
[TBL] [Abstract][Full Text] [Related]
16. Co-incident signalling between mu-opioid and M3 muscarinic receptors at the level of Ca2+ release from intracellular stores: lack of evidence for Ins(1,4,5)P3 receptor sensitization.
Samways DS; Li WH; Conway SJ; Holmes AB; Bootman MD; Henderson G
Biochem J; 2003 Nov; 375(Pt 3):713-20. PubMed ID: 12880387
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide FF receptors exert contractile activity via inhibition of nitric oxide release in the mouse distal colon.
Fang Q; Guo J; Chang M; Chen LX; Chen Q; Wang R
Peptides; 2005 May; 26(5):791-7. PubMed ID: 15808909
[TBL] [Abstract][Full Text] [Related]
18. Opposite alterations of NPFF1 and NPFF2 neuropeptide FF receptor density in the triple MOR/DOR/KOR-opioid receptor knockout mouse brains.
Gouardères C; Kieffer BL; Zajac JM
J Chem Neuroanat; 2004 May; 27(2):119-28. PubMed ID: 15121216
[TBL] [Abstract][Full Text] [Related]
19. Biochemical anti-opioid action of NPFF2 receptors in rat spinal cord.
Gouardères C; Zajac JM
Neurosci Res; 2007 May; 58(1):91-4. PubMed ID: 17337079
[TBL] [Abstract][Full Text] [Related]
20. Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking.
Onoprishvili I; Andria ML; Kramer HK; Ancevska-Taneva N; Hiller JM; Simon EJ
Mol Pharmacol; 2003 Nov; 64(5):1092-100. PubMed ID: 14573758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
